REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis
Europe - FRA:RDC - NL0012044747 - Common Stock
61.6 EUR
-0.15 (-0.24%)
We assign a fundamental rating of 3 out of 10 to RDC. RDC was compared to 21 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of RDC is average, but there are quite some concerns on its profitability. While showing a medium growth rate, RDC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
RDC had negative earnings in the past year.
RDC had a positive operating cash flow in the past year.
RDC had negative earnings in each of the past 5 years.
Of the past 5 years RDC 4 years had a positive operating cash flow.
1.2 Ratios
RDC has a Return On Assets of -2.88%. This is amonst the worse of the industry: RDC underperforms 80.95% of its industry peers.
RDC has a Return On Equity of -7.01%. This is amonst the worse of the industry: RDC underperforms 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROIC | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 22.88%, RDC is in line with its industry, outperforming 47.62% of the companies in the same industry.
In the last couple of years the Gross Margin of RDC has grown nicely.
RDC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
2. Health
2.1 Basic Checks
RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RDC has been reduced compared to 1 year ago.
RDC has more shares outstanding than it did 5 years ago.
RDC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.25 indicates that RDC is not in any danger for bankruptcy at the moment.
RDC has a better Altman-Z score (3.25) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that RDC is somewhat dependend on debt financing.
RDC's Debt to Equity ratio of 0.62 is fine compared to the rest of the industry. RDC outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.25 |
ROIC/WACCN/A
WACC6.72%
2.3 Liquidity
A Current Ratio of 1.68 indicates that RDC should not have too much problems paying its short term obligations.
RDC's Current ratio of 1.68 is amongst the best of the industry. RDC outperforms 90.48% of its industry peers.
A Quick Ratio of 1.23 indicates that RDC should not have too much problems paying its short term obligations.
RDC's Quick ratio of 1.23 is amongst the best of the industry. RDC outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
RDC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.61%.
RDC shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.68%.
RDC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.59% yearly.
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.47%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
3.2 Future
The Earnings Per Share is expected to grow by 52.47% on average over the next years. This is a very strong growth
Based on estimates for the next years, RDC will show a quite strong growth in Revenue. The Revenue will grow by 18.66% on average per year.
EPS Next Y49.41%
EPS Next 2Y55.83%
EPS Next 3Y51.95%
EPS Next 5Y52.47%
Revenue Next Year25.61%
Revenue Next 2Y22.72%
Revenue Next 3Y21.15%
Revenue Next 5Y18.66%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for RDC. In the last year negative earnings were reported.
RDC is valuated quite expensively with a Price/Forward Earnings ratio of 74.66.
Based on the Price/Forward Earnings ratio, RDC is valued more expensive than 85.71% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of RDC to the average of the S&P500 Index (31.86), we can say RDC is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 74.66 |
4.2 Price Multiples
80.95% of the companies in the same industry are cheaper than RDC, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 34.72 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as RDC's earnings are expected to grow with 51.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.83%
EPS Next 3Y51.95%
5. Dividend
5.1 Amount
RDC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:RDC (11/7/2025, 5:29:57 PM)
61.6
-0.15 (-0.24%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners48.6%
Inst Owner ChangeN/A
Ins Owners7.4%
Ins Owner ChangeN/A
Market Cap1.27B
Revenue(TTM)2.82B
Net Income(TTM)-35.19M
Analysts78.57
Price Target155.65 (152.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-1.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.42%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.91%
PT rev (3m)-7.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.46%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 74.66 | ||
| P/S | 0.45 | ||
| P/FCF | N/A | ||
| P/OCF | 38.63 | ||
| P/B | 2.52 | ||
| P/tB | 12.73 | ||
| EV/EBITDA | 34.72 |
EPS(TTM)-1.8
EYN/A
EPS(NY)0.83
Fwd EY1.34%
FCF(TTM)-2.99
FCFYN/A
OCF(TTM)1.59
OCFY2.59%
SpS137.07
BVpS24.41
TBVpS4.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.88% | ||
| ROE | -7.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.88% | ||
| FCFM | N/A |
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score3
Asset Turnover2.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.5 | ||
| Cap/Depr | 136.74% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 90.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.68 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 3.25 |
F-Score3
WACC6.72%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.47%
EPS Next Y49.41%
EPS Next 2Y55.83%
EPS Next 3Y51.95%
EPS Next 5Y52.47%
Revenue 1Y (TTM)26.68%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%25.18%
Revenue Next Year25.61%
Revenue Next 2Y22.72%
Revenue Next 3Y21.15%
Revenue Next 5Y18.66%
EBIT growth 1Y-72.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.27%
EBIT Next 3Y97.51%
EBIT Next 5Y68.49%
FCF growth 1Y-2656.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.32%
OCF growth 3Y23.87%
OCF growth 5YN/A
REDCARE PHARMACY NV / RDC.DE FAQ
Can you provide the ChartMill fundamental rating for REDCARE PHARMACY NV?
ChartMill assigns a fundamental rating of 3 / 10 to RDC.DE.
What is the valuation status of REDCARE PHARMACY NV (RDC.DE) stock?
ChartMill assigns a valuation rating of 1 / 10 to REDCARE PHARMACY NV (RDC.DE). This can be considered as Overvalued.
Can you provide the profitability details for REDCARE PHARMACY NV?
REDCARE PHARMACY NV (RDC.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for RDC stock?
The Earnings per Share (EPS) of REDCARE PHARMACY NV (RDC.DE) is expected to grow by 49.41% in the next year.